[go: up one dir, main page]

AR115987A1 - ANTI-GDF15 ANTIBODIES, COMPOSITIONS AND METHODS OF USE - Google Patents

ANTI-GDF15 ANTIBODIES, COMPOSITIONS AND METHODS OF USE

Info

Publication number
AR115987A1
AR115987A1 ARP190102361A ARP190102361A AR115987A1 AR 115987 A1 AR115987 A1 AR 115987A1 AR P190102361 A ARP190102361 A AR P190102361A AR P190102361 A ARP190102361 A AR P190102361A AR 115987 A1 AR115987 A1 AR 115987A1
Authority
AR
Argentina
Prior art keywords
methods
compositions
antibodies
gdf15 antibodies
gdf15
Prior art date
Application number
ARP190102361A
Other languages
Spanish (es)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of AR115987A1 publication Critical patent/AR115987A1/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente proporciona anticuerpos y fragmentos de unión al antígeno de los mismos que se unen específicamente a GDF15, así como métodos y usos de los anticuerpos.The present provides antibodies and antigen-binding fragments thereof that specifically bind GDF15, as well as methods and uses of the antibodies.

ARP190102361A 2018-08-20 2019-08-20 ANTI-GDF15 ANTIBODIES, COMPOSITIONS AND METHODS OF USE AR115987A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201862765289P 2018-08-20 2018-08-20

Publications (1)

Publication Number Publication Date
AR115987A1 true AR115987A1 (en) 2021-03-17

Family

ID=75905110

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP190102361A AR115987A1 (en) 2018-08-20 2019-08-20 ANTI-GDF15 ANTIBODIES, COMPOSITIONS AND METHODS OF USE

Country Status (1)

Country Link
AR (1) AR115987A1 (en)

Similar Documents

Publication Publication Date Title
CO2021001893A2 (en) Anti-gdf15 antibodies, compositions and methods of use
CO2018011364A2 (en) Anti-il-33 antibodies, compositions, methods and uses thereof
NI201800055A (en) ANTIBODIES THAT SPECIFICALLY BIND PD-1 AND ITS USES.
UY40829A (en) ANTI-PHF-TAU ANTIBODIES AND THEIR USES
MX2021002690A (en) Anti-avb8 antibodies and compositions and uses thereof.
UY39798A (en) ANTI-CCR8 ANTIBODIES AND USES THEREOF
MX2024006565A (en) PRO/LATENT ANTI-MYOSTATIN ANTIBODIES AND METHOD OF USE THEREOF.
ECSP19026178A (en) ANTI-PD-1 ANTIBODIES AND THEIR USES
ECSP19050049A (en) ANTI-OX40 ANTIBODIES AND THEIR USES
CO2020012347A2 (en) Anti-hla-g antibodies and their uses.
CO2020012360A2 (en) Multispecific antibodies and their use
ECSP18005520A (en) FACTOR XI ANTIBODIES AND METHODS OF USE
ECSP18033227A (en) Agonist Antibodies That Specifically Bind Human CD40 and Methods of Use
MX383464B (en) ANTI-PD-1 ANTIBODIES, ACTIVATABLE ANTI-PD-1 ANTIBODIES, AND METHODS OF USING THE SAME.
ECSP17045736A (en) COMPOSITIONS AND METHODS FOR ANTIBODIES TARGETING BMP6
MX2018016364A (en) ANTI-PD-L1 ANTIBODIES.
CU24533B1 (en) ANTIBODIES OR FRAGMENTS THEREOF THAT BIND THYMIC STROMAL LYMPHOPOYETIN (TSLP) AND PHARMACEUTICAL COMPOSITIONS THEREOF
UY36889A (en) MOLECULES OF JOINT TO TIMICA STROMAL LYMPHOPOYETIN (TSLP) AND METHODS OF USE OF THE MOLECULES
MX2019004690A (en) Antibody constructs.
MX2019007554A (en) BINDING PROTEINS TO THE ANTI-NEUROPYLIN ANTIGEN, AND THEIR METHODS OF USE.
UY37030A (en) ANTIBODIES DIRECTED TO CD32B AND METHODS OF USE OF THE SAME
BR112021011124A2 (en) Anellosomes and methods of use
MX2020013428A (en) Monoclonal antibodies against human tim-3.
MX2020003093A (en) Novel anti-cd19 antibodies.
CO2019013718A2 (en) Anti-trkb antibodies